|
Pro-Dex ، Inc. (PDEX) تقييم DCF
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Pro-Dex, Inc. (PDEX) Bundle
Simplify Pro-Dex ، Inc. (PDEX) تقييم مع هذه الآلة الحاسبة DCF القابلة للتخصيص! يضم REAL Pro-Dex ، Inc. (PDEX) ومدخلات التنبؤ القابلة للتعديل ، يمكنك اختبار السيناريوهات وكشف القيمة العادلة Pro-Dex ، Inc. (PDEX) في دقائق.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34.8 | 38.0 | 42.0 | 46.1 | 53.8 | 60.1 | 67.0 | 74.7 | 83.4 | 93.0 |
| Revenue Growth, % | 0 | 9.17 | 10.55 | 9.62 | 16.83 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 |
| EBITDA | 8.8 | 8.1 | 6.0 | 6.6 | 8.3 | 10.9 | 12.1 | 13.5 | 15.1 | 16.8 |
| EBITDA, % | 25.12 | 21.23 | 14.2 | 14.36 | 15.48 | 18.08 | 18.08 | 18.08 | 18.08 | 18.08 |
| Depreciation | .6 | .7 | .7 | .9 | 1.2 | 1.1 | 1.3 | 1.4 | 1.6 | 1.8 |
| Depreciation, % | 1.76 | 1.91 | 1.73 | 1.86 | 2.15 | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 |
| EBIT | 8.1 | 7.3 | 5.2 | 5.8 | 7.2 | 9.7 | 10.9 | 12.1 | 13.5 | 15.1 |
| EBIT, % | 23.36 | 19.32 | 12.47 | 12.5 | 13.32 | 16.2 | 16.2 | 16.2 | 16.2 | 16.2 |
| Total Cash | 9.0 | 5.0 | 1.6 | 4.1 | 6.8 | 7.7 | 8.6 | 9.6 | 10.7 | 12.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 5.2 | 10.9 | 15.4 | 10.0 | 13.9 | 15.3 | 17.1 | 19.1 | 21.3 | 23.7 |
| Account Receivables, % | 14.8 | 28.75 | 36.59 | 21.59 | 25.79 | 25.51 | 25.51 | 25.51 | 25.51 | 25.51 |
| Inventories | 8.2 | 8.4 | 12.7 | 16.2 | 15.3 | 16.7 | 18.7 | 20.8 | 23.2 | 25.9 |
| Inventories, % | 23.65 | 22.19 | 30.16 | 35.08 | 28.36 | 27.89 | 27.89 | 27.89 | 27.89 | 27.89 |
| Accounts Payable | 2.0 | 2.3 | 3.8 | 2.3 | 4.5 | 4.1 | 4.5 | 5.1 | 5.6 | 6.3 |
| Accounts Payable, % | 5.64 | 6.02 | 8.95 | 4.91 | 8.38 | 6.78 | 6.78 | 6.78 | 6.78 | 6.78 |
| Capital Expenditure | -.6 | -8.3 | -1.7 | -1.0 | -1.0 | -3.8 | -4.2 | -4.7 | -5.2 | -5.8 |
| Capital Expenditure, % | -1.62 | -21.84 | -3.97 | -2.11 | -1.83 | -6.28 | -6.28 | -6.28 | -6.28 | -6.28 |
| Tax Rate, % | 19.25 | 19.25 | 19.25 | 19.25 | 19.25 | 19.25 | 19.25 | 19.25 | 19.25 | 19.25 |
| EBITAT | 6.3 | 5.8 | 5.1 | 4.3 | 5.8 | 8.0 | 8.9 | 9.9 | 11.1 | 12.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -5.1 | -7.4 | -3.1 | 4.6 | 5.2 | 2.0 | 2.7 | 3.0 | 3.4 | 3.8 |
| WACC, % | 6.19 | 6.19 | 6.27 | 6.18 | 6.2 | 6.2 | 6.2 | 6.2 | 6.2 | 6.2 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 12.2 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 4 | |||||||||
| Terminal Value | 177 | |||||||||
| Present Terminal Value | 131 | |||||||||
| Enterprise Value | 144 | |||||||||
| Net Debt | 11 | |||||||||
| Equity Value | 133 | |||||||||
| Diluted Shares Outstanding, MM | 4 | |||||||||
| Equity Value Per Share | 37.14 |
What You Will Get
- Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Pro-Dex, Inc.’s (PDEX) financial data pre-loaded to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model that can be tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.
Key Features
- Comprehensive Historical Data: Pro-Dex, Inc.'s (PDEX) financial statements and detailed forecasts are readily available.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins to suit your analysis.
- Real-Time Valuation: Instantly view the recalculated intrinsic value of Pro-Dex, Inc. (PDEX).
- Intuitive Visualizations: Engaging dashboard charts present valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the prebuilt Excel template featuring Pro-Dex, Inc.'s (PDEX) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the updated results, including Pro-Dex, Inc.'s (PDEX) intrinsic value.
- Step 5: Utilize the outputs to make informed investment choices or create detailed reports.
Why Choose Pro-Dex, Inc. (PDEX)?
- Innovative Solutions: Cutting-edge technology tailored for your specific needs.
- Enhanced Efficiency: Streamlined processes help you achieve better results faster.
- Customizable Products: Adapt our offerings to align with your unique requirements.
- User-Friendly Interface: Intuitive design ensures a smooth experience for all users.
- Industry Expertise: Backed by a team of professionals dedicated to excellence and support.
Who Should Use Pro-Dex, Inc. (PDEX)?
- Healthcare Professionals: Understand how Pro-Dex, Inc. (PDEX) innovates in medical device manufacturing.
- Investors: Evaluate investment opportunities and assess market trends related to Pro-Dex, Inc. (PDEX).
- Researchers: Utilize data on Pro-Dex, Inc. (PDEX) for studies in medical technology advancements.
- Business Analysts: Analyze Pro-Dex, Inc. (PDEX)'s performance metrics and industry positioning.
- Entrepreneurs: Learn from Pro-Dex, Inc. (PDEX)'s business strategies in the healthcare sector.
What the Template Contains
- Preloaded PDEX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.